Tiotropium Positioned in Step 3 and Step 4 Care for Asthma: Japanese Society of Allergology’s Revised Guidelines

June 5, 2015
The Japanese Society of Allergology (JSA) has revised its Guidelines for the Prevention and Management of Asthma for the first time in three years. The new guidelines position tiotropium (brand name: Spiriva), a long-acting muscarinic antagonist (LAMA) that obtained an...read more